-
1 Comment
Shanghai Runda Medical Technology Co., Ltd is currently in a long term downtrend where the price is trading 5.7% below its 200 day moving average.
From a valuation standpoint, the stock is 89.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Shanghai Runda Medical Technology Co., Ltd's total revenue rose by 6.6% to $2B since the same quarter in the previous year.
Its net income has increased by 610.8% to $125M since the same quarter in the previous year.
Finally, its free cash flow grew by 2564.6% to $120M since the same quarter in the previous year.
Based on the above factors, Shanghai Runda Medical Technology Co., Ltd gets an overall score of 4/5.
| ISIN | CNE100002318 |
|---|---|
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Exchange | SHG |
| CurrencyCode | CNY |
| Beta | 0.41 |
|---|---|
| PE Ratio | 290.5 |
| Market Cap | 11B |
| Target Price | 12.25 |
| Dividend Yield | None |
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technical services; and logistic services. In addition, it is involved in the software development; provision of information system integration and consulting services; sale of chemicals; rental services; sale of medical devices; maintenance of electronic and mechanical equipment; import and export of technology; offers general cargo warehousing and road freight transportation services; and wholesale of medicines. The company was incorporated in 1999 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603108.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
